Psychemedics Corp

Psychemedics Corp

Psychemedics Corp is a publicly traded company specializing in hair drug testing. It was founded in 1987 and is headquartered in the United States. The firm's primary business is the analysis of hair samples to detect drug use over an extended period, serving corporate, clinical, and legal clients. Its technology is designed to be non-invasive and provide a longer detection window than urine or blood tests. The company's strategy centers on marketing its hair testing services to employers for pre-employment and random testing, as well as to clinical and forensic clients. Its target market includes large corporations, government agencies, and healthcare providers. The firm's revenue stream comes from testing fees and product sales related to sample collection kits. Public financial disclosures indicate revenue in the tens of millions of dollars annually (per SEC filings). Psychemedics operates with a limited public profile, and no detailed team structure or additional offices beyond its headquarters are disclosed in available public records. The firm's team size is not publicly stated, but its workforce is estimated at under 500 employees based on revenue scale (per public filings). The company's stock is traded on the Nasdaq under the symbol PMD. No recent operational events (within 24 months) are verifiable from high-quality public sources. The structural differentiator of Psychemedics is its focused business model as a public company in a niche diagnostic services space. Unlike many family offices or private investment firms, Psychemedics operates as a for-profit corporation with a single revenue stream from drug testing services. Its corporate structure is shaped by public listing requirements and shareholder accountability, distinct from private investment entities.